Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Xeris Pharmaceuticals, Inc.:
We consent to the use of our report dated March 21, 2018, except as to Note 15, as to which the date is June 11, 2018, incorporated by reference herein.
/s/ KPMG LLP
Chicago, Illinois
February 8, 2019
